Detalhe da pesquisa
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078508
2.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
3.
Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572567
4.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
5.
Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
Br J Haematol
; 202(1): 48-53, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951278
6.
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.
Blood
; 137(2): 216-231, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024998
7.
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Br J Haematol
; 198(3): 492-502, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485402
8.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
9.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Lancet Oncol
; 22(6): 765-778, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930323
10.
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Br J Cancer
; 125(7): 939-947, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400804
11.
Targeting the tumor microenvironment in chronic lymphocytic leukemia.
Haematologica
; 106(9): 2312-2324, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882636
12.
The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells.
Haematologica
; 105(6): 1593-1603, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537685
13.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
14.
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Blood
; 128(4): 563-73, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27252234
15.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
16.
In vitro and in vivo evidence for uncoupling of B-cell receptor internalization and signaling in chronic lymphocytic leukemia.
Haematologica
; 103(3): 497-505, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242301
17.
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
Eur J Haematol
; 100(1): 98-103, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094407
18.
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper.
Br J Haematol
; 196(4): 864-870, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607388
19.
Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Br J Haematol
; 196(1): 70-78, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498258
20.
Guideline for the treatment of chronic lymphocytic leukaemia.
Br J Haematol
; 197(5): 544-557, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313007